EAM
IMVTW

Eventide Asset Management’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

Eventide Asset Management’s Portfolio IMVTW Stock Details IMVTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-651,900
Closed -$1.56M – 145
2020
Q1 		$1.56M Buy
+651,900
New +$1.25M 0.05% 114

Eventide Asset Management's IMVTW Position: Q2 2020 in Review

Eventide Asset Management sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 651,900 shares — an estimated $1.56M sold.

Eventide Asset Management first reported a position in IMVTW in Q1 2020 and held it in 1 quarter. The position peaked at $1.56M in Q1 2020. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

  • Eventide Asset Management reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
  • Eventide Asset Management sold 651,900 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $1.56M.
  • Eventide Asset Management first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q1 2020 and held it in 1 quarter.
  • Eventide Asset Management's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $1.56M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on Eventide Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.